Drug-induced interstitial lung disease: a real-world pharmacovigilance study of the FDA Adverse Event Reporting System from 2004 to 2021.

Tingting JiangHui SuJing XuChen LiNi ZhangYanping LiYuanlin WuRui NiYue MingZiwei LiLi LiYao Liu

Published in: Therapeutic advances in drug safety (2024)

We found the top drugs and drug classes that were associated with DILD in the FAERS, which provides a real-world window for different ages, sexes, and countries to formulate precise pharmacovigilance policies.

Keyphrases

drug induced
adverse drug
liver injury
interstitial lung disease
systemic sclerosis
rheumatoid arthritis
idiopathic pulmonary fibrosis
public health
emergency department